UltraMAB®, the Ultra Specific Antibodies for Anatomic Pathology
- UltraMAB specificity: tested with High Density Protein Microarray
- UltraMAB performance: validated for IHC staining with over 25 normal and cancer human tissues
Current targets of UltraMABs include HER2, ALK, Ki67, ERCC1, Beta-Catenin, IDH1 and other important diagnostic target.
Visit UltraMAB for more details and targets.
TrueMAB™ validated for IHC
OriGene also generated TrueMAB mouse monoclonal antibodies against full-length human proteins and tested them for IHC staining.
Visit TrueMAB to search for your targets.
SDIX, OriGene’s wholly owned subsidiary, has manufactured OriGene’s antibodies, including UltraMAB®, in a GMP environment and obtained CE marking for these products. The antibodies are intended for detection of specific protein expression in frozen or formalin fixed human tissues and cells. These antibodies are for in vitro diagnostic (IVD) use*.
Visit IVD antibodies for your targets.